In addition to Regeneron, Giuliani said he received dexamethasone, a steroid, and remdesivir, an antiviral drug, as part of his COVID-19 regimen. Those drugs are more widely available in the U.S. than monoclonal antibody treatments, though some parts of the country are still experiencing regional shortages, according to public health experts.